Wikidata

(Q63320135)

English

Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Efficacy and Safety Study of MCI-186 for Treatment of the Patients With Amyotrophic Lateral Sclerosis (ALS) 2 (English)
0 references
country
Japan
0 references
start time
December 2011
0 references
end time
September 2014
0 references
number of participants
137
0 references
minimum age
20 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63320135&oldid=2149246938"